Cargando…
Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms
Among the complications of diabetes, cardiovascular events and cardiac insufficiency are considered two of the most important causes of death. Experimental and clinical evidence supports the effectiveness of SGLT2i for improving cardiac dysfunction. SGLT2i treatment benefits metabolism, microcircula...
Autores principales: | Huang, Keming, Luo, Xianling, Liao, Bin, Li, Guang, Feng, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103501/ https://www.ncbi.nlm.nih.gov/pubmed/37055837 http://dx.doi.org/10.1186/s12933-023-01816-5 |
Ejemplares similares
-
New insights into the role of melatonin in diabetic cardiomyopathy
por: Huang, Keming, et al.
Publicado: (2022) -
Multi-omics insights into potential mechanism of SGLT2 inhibitors cardiovascular benefit in diabetic cardiomyopathy
por: Xi, Yangbo, et al.
Publicado: (2022) -
The Importance of SGLT-2 Inhibitors as Both the Prevention and the Treatment of Diabetic Cardiomyopathy
por: Kowalska, Klaudia, et al.
Publicado: (2022) -
SGLT2 Inhibitors: A Novel Player in the Treatment and Prevention of Diabetic Cardiomyopathy
por: Li, Na, et al.
Publicado: (2020) -
Evolving insights into the pleiotropic cardioprotective mechanisms of SGLT2 inhibitors
por: Fender, Anke C., et al.
Publicado: (2023)